Literature DB >> 28281925

Infectious prions and proteinopathies.

Rona M Barron1.   

Abstract

Transmissible spongiform encephalopathies (TSEs) are caused by an infectious agent that is thought to consist of only misfolded and aggregated prion protein (PrP). Unlike conventional micro-organisms, the agent spreads and propagates by binding to and converting normal host PrP into the abnormal conformer, increasing the infectious titre. Synthetic prions, composed of refolded fibrillar forms of recombinant PrP (rec-PrP) have been generated to address whether PrP aggregates alone are indeed infectious prions. In several reports, the development of TSE disease has been described following inoculation and passage of rec-PrP fibrils in transgenic mice and hamsters. However in studies described here we show that inoculation of rec-PrP fibrils does not always cause clinical TSE disease or increased infectious titre, but can seed the formation of PrP amyloid plaques in PrP-P101L knock-in transgenic mice (101LL). These data are reminiscent of the "prion-like" spread of misfolded protein in other models of neurodegenerative disease following inoculation of transgenic mice with pre-formed amyloid seeds. Protein misfolding, even when the protein is PrP, does not inevitably lead to the development of an infectious TSE disease. It is possible that most in vivo and in vitro produced misfolded PrP is not infectious and that only a specific subpopulation is associated with infectivity and neurotoxicity.

Entities:  

Keywords:  TSE; amyloid; prion; prion-like; synthetic prions

Mesh:

Substances:

Year:  2017        PMID: 28281925      PMCID: PMC5360137          DOI: 10.1080/19336896.2017.1283464

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  31 in total

1.  Lower specific infectivity of protease-resistant prion protein generated in cell-free reactions.

Authors:  Mikael Klingeborn; Brent Race; Kimberly D Meade-White; Bruce Chesebro
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

2.  Eight prion strains have PrP(Sc) molecules with different conformations.

Authors:  J Safar; H Wille; V Itri; D Groth; H Serban; M Torchia; F E Cohen; S B Prusiner
Journal:  Nat Med       Date:  1998-10       Impact factor: 53.440

3.  Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein.

Authors:  C I Lasmézas; J P Deslys; O Robain; A Jaegly; V Beringue; J M Peyrin; J G Fournier; J J Hauw; J Rossier; D Dormont
Journal:  Science       Date:  1997-01-17       Impact factor: 47.728

4.  Isolation of novel synthetic prion strains by amplification in transgenic mice coexpressing wild-type and anchorless prion proteins.

Authors:  Gregory J Raymond; Brent Race; Jason R Hollister; Danielle K Offerdahl; Roger A Moore; Ravindra Kodali; Lynne D Raymond; Andrew G Hughson; Rebecca Rosenke; Dan Long; David W Dorward; Gerald S Baron
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

5.  Synthetic mammalian prions.

Authors:  Giuseppe Legname; Ilia V Baskakov; Hoang-Oanh B Nguyen; Detlev Riesner; Fred E Cohen; Stephen J DeArmond; Stanley B Prusiner
Journal:  Science       Date:  2004-07-30       Impact factor: 47.728

6.  Pathology of SSLOW, a transmissible and fatal synthetic prion protein disorder, and comparison with naturally occurring classical transmissible spongiform encephalopathies.

Authors:  M Jeffrey; G McGovern; N Makarava; L González; Y-S Kim; R G Rohwer; I V Baskakov
Journal:  Neuropathol Appl Neurobiol       Date:  2014-04       Impact factor: 8.090

Review 7.  Protein Transmission, Seeding and Degradation: Key Steps for α-Synuclein Prion-Like Propagation.

Authors:  Abid Oueslati; Methodios Ximerakis; Kostas Vekrellis
Journal:  Exp Neurobiol       Date:  2014-12-12       Impact factor: 3.261

8.  Recombinant prion protein induces a new transmissible prion disease in wild-type animals.

Authors:  Natallia Makarava; Gabor G Kovacs; Olga Bocharova; Regina Savtchenko; Irina Alexeeva; Herbert Budka; Robert G Rohwer; Ilia V Baskakov
Journal:  Acta Neuropathol       Date:  2010-01-06       Impact factor: 17.088

9.  Protease-sensitive synthetic prions.

Authors:  David W Colby; Rachel Wain; Ilia V Baskakov; Giuseppe Legname; Christina G Palmer; Hoang-Oanh B Nguyen; Azucena Lemus; Fred E Cohen; Stephen J DeArmond; Stanley B Prusiner
Journal:  PLoS Pathog       Date:  2010-01-22       Impact factor: 6.823

10.  Gerstmann-Sträussler-Scheinker disease subtypes efficiently transmit in bank voles as genuine prion diseases.

Authors:  Laura Pirisinu; Michele A Di Bari; Claudia D'Agostino; Stefano Marcon; Geraldina Riccardi; Anna Poleggi; Mark L Cohen; Brian S Appleby; Pierluigi Gambetti; Bernardino Ghetti; Umberto Agrimi; Romolo Nonno
Journal:  Sci Rep       Date:  2016-02-04       Impact factor: 4.379

View more
  4 in total

1.  Comparative analysis of heparin affecting the biochemical properties of chicken and murine prion proteins.

Authors:  Li-Juan Wang; Xiao-Dan Gu; Xiao-Xiao Li; Liang Shen; Hong-Fang Ji
Journal:  PLoS One       Date:  2021-02-18       Impact factor: 3.240

Review 2.  Prion strains viewed through the lens of cryo-EM.

Authors:  Szymon W Manka; Adam Wenborn; John Collinge; Jonathan D F Wadsworth
Journal:  Cell Tissue Res       Date:  2022-08-27       Impact factor: 4.051

3.  Recent Advances in Understanding Mammalian Prion Structure: A Mini Review.

Authors:  Cassandra Terry; Jonathan D F Wadsworth
Journal:  Front Mol Neurosci       Date:  2019-07-09       Impact factor: 5.639

4.  Spontaneous generation of prions and transmissible PrP amyloid in a humanised transgenic mouse model of A117V GSS.

Authors:  Emmanuel A Asante; Jacqueline M Linehan; Andrew Tomlinson; Tatiana Jakubcova; Shyma Hamdan; Andrew Grimshaw; Michelle Smidak; Asif Jeelani; Akin Nihat; Simon Mead; Sebastian Brandner; Jonathan D F Wadsworth; John Collinge
Journal:  PLoS Biol       Date:  2020-06-09       Impact factor: 8.029

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.